Clinical trial

Vielight Neuro RX Gamma - Feasibility Pilot

NCT03328195

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-12-04

PhaseNA

Study timeline

Study start (actual)2017-12-04Date precision: day

Registry last updated2023-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

Neuro RX Gamma synchronousDEVICE

ShamDEVICE

Neuro RX Gamma asynchronousDEVICE

Sponsors & collaborators

Vielight Inc.lead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03328195 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.